AN2 Therapeutics, Inc. ($ANTX)
Prior Stephen David โ Chief Strategy Officer
Shares
3,604
Price
$1.00
Total Value
$3,614.81
Nearby Earnings
No earnings within 2 weeks of this transaction.
Transaction Details
| Insider | Prior Stephen David |
|---|---|
| Title | Chief Strategy Officer |
| Transaction Date | Jan 5, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Jan 8, 2026 |
| Document Date | Jan 5, 2026 |
| Shares Sold | 3,604 |
| Price per Share | $1.00 |
| Total Value | $3,614.81 |
| Shares Owned After | 61,944 |
| Derivative | No |
| Accession Number | 0001193125-26-006770 |
| Document | View SEC Filing |